Iodipamide sodium

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 412843

CAS#: 2618-26-0 (sodium)

Description: Iodipamide sodium is a water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.


Chemical Structure

img
Iodipamide sodium
CAS# 2618-26-0 (sodium)

Theoretical Analysis

MedKoo Cat#: 412843
Name: Iodipamide sodium
CAS#: 2618-26-0 (sodium)
Chemical Formula: C20H12I6N2Na2O6
Exact Mass: 1,183.48
Molecular Weight: 1,183.730
Elemental Analysis: C, 20.29; H, 1.02; I, 64.32; N, 2.37; Na, 3.88; O, 8.11

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 606-17-7 (free base)   3521-84-4 (meglumine)   2618-26-0 (sodium)  

Synonym: Iodipamide sodium; EINECS 220-049-3;

IUPAC/Chemical Name: Benzoic acid, 3,3'-(adipoyldiimino)bis(2,4,6-triiodo-, disodium salt

InChi Key: SIZXNBZGPPPFHM-UHFFFAOYSA-L

InChi Code: InChI=1S/C20H14I6N2O6.2Na/c21-7-5-9(23)17(15(25)13(7)19(31)32)27-11(29)3-1-2-4-12(30)28-18-10(24)6-8(22)14(16(18)26)20(33)34;;/h5-6H,1-4H2,(H,27,29)(H,28,30)(H,31,32)(H,33,34);;/q;2*+1/p-2

SMILES Code: O=C(NC1=C(I)C(C([O-])=O)=C(I)C=C1I)CCCCC(NC2=C(I)C(C([O-])=O)=C(I)C=C2I)=O.[Na+].[Na+]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 1,183.73 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Feld GK, Loeb PM, Berk RN, Wheeler HO. The choleretic effect of iodipamide. J Clin Invest. 1975 Mar;55(3):528-35. doi: 10.1172/JCI107959. PMID: 1117066; PMCID: PMC301780.

2: Thompson WM, Jones RS, Lang JH, Amberg JR. Effect of iopanoate on the biliary and urinary excretion of iodipamide. Invest Radiol. 1978 Jan-Feb;13(1):79-84. doi: 10.1097/00004424-197801000-00016. PMID: 632052.

3: Burgener FA. Pharmacocholangiography. Rofo. 1978 Feb;128(2):135-7. doi: 10.1055/s-0029-1230810. PMID: 147207.

4: Täfler M, Ziegler K, Frimmer M. Iodipamide uptake by rat liver plasma membrane vesicles enriched in the sinusoidal fraction: evidence for a carrier- mediated transport dependent on membrane potential. Biochim Biophys Acta. 1986 Feb 13;855(1):157-68. doi: 10.1016/0005-2736(86)90200-2. PMID: 3942739.

5: Burgener FA, Fischer HW. The effect of sodium taurocholate on biliary iodipamide excretion in the dog. Gastroenterology. 1976 Sep;71(3):475-8. PMID: 950099.

6: Swanson DP, Dick TJ, Simms SM, Thrall JH. Product selection criteria for intravascular ionic contrast media. Clin Pharm. 1985 Sep-Oct;4(5):527-38. PMID: 3902331.

7: KIMBEL KH, HEINKEL K, BORNER W. Die Ausscheidung des Na-Salzes des Adipinsäure-bis[2, 4, 6-trijod-3-carboxy-anilid] bei der Ratte [Sodium iodipamide excretion in rats]. Arzneimittelforschung. 1956 Apr;6(4):225-6. German. PMID: 13315106.

8: Eil C, Chestnut RY. The effects of radiographic contrast agents and other compounds on the nuclear binding of L-[125I]triiodothyronine in dispersed human skin fibroblasts. J Clin Endocrinol Metab. 1985 Mar;60(3):548-52. doi: 10.1210/jcem-60-3-548. PMID: 2982901.

9: FLEISCHMANN E. Erfahrung mit Bilijodon-Natrium, einem neuen oralen Gallenkontrastmittel [Experience with sodium iodipamide, a new oral contrast medium for cholecystography]. Klin Med Osterr Z Wiss Prakt Med. 1957 May;12(5):209-12. German. PMID: 13439904.

10: Pfister RC, Hutter AM Jr, Newhouse JH, Yoder IC, Travers E. Contrast-medium- induced electrocardiographic abnormalities: comparison of bolus and infusion of methylglucamine iodamide and methylglucamine/sodium diatrizoate. AJR Am J Roentgenol. 1983 Jan;140(1):149-53. doi: 10.2214/ajr.140.1.149. PMID: 6600306.